Disruption of the c/ebpα Gene in Adult Mouse liver

REFERENCES

• Albrecht, J. H., A. H. Meyer, and M. Y. Hu. 1997. Regulation of cyclindependent kinase inhibitor p21WAF1/Cip1/Sdi1 gene expression in hepatic regeneration. Hepatology 25:557–563.
   PubMedGoogle Scholar
• Anton, M., and F. L. Graham. 1995. Site-specific recombination mediated by an adenovirus vector expressing the Cre recombinase protein: a molecular switch for control of gene expression. J. Virol. 69:4600–4606.
   PubMed Web of Science ®Google Scholar
• Bosma, P. J., B. Seppen, G. C. Bakker, R. P. O. Elferink, J. R. Chowdhury, N. R. Chowdhury, and P. L. Jansen. 1994. Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucurodidating isoform in man. J. Biol. Chem. 269:17960–17964.
   PubMed Web of Science ®Google Scholar
• Drazan, K. E., M. E. Csete, X. D. Shen, D. Bullington, G. Cottle, R. W. Busuttil, and A. Shaked. 1995. Hepatic function is preserved following liver-directed, adenovirus-mediated gene transfer. J. Surg. Res. 59:299–304.
   PubMedGoogle Scholar
• Fang, B., R. C. Eisensmith, X. H. C. Li, M. J. Finegold, A. Shedlovsky, W. Dove, and S. L. C. Woo. 1994. Gene therapy for phenylketonuria: phenotypic correction in a genetically deficient mouse model by adenovirus-mediated hepatic gene transfer. Gene Ther. 1:247–254.
   PubMed Web of Science ®Google Scholar
• Graham, F. L., and L. Previec. 1995. Methods for construction of adenovirus vectors. Mol. Biotechnol. 3:207–220.
   PubMed Web of Science ®Google Scholar
• Granner, D., T. Andreone, K. Sasaki, and E. Beale. 1983. Inhibition of transcription of the phosphoenolpyruvate carboxykinase gene by insulin. Nature 305:549–551.
   PubMed Web of Science ®Google Scholar
• Harper, J. W., S. J. Elledge, D. Keyomarsi, L. H. Dynlacht, P. Tsai, S. Zhang, C. Dobrowolshi, L. Bai, E. Connell-Crowley, M. P. F. Swinde, and N. Wei. 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6:387–400.
   PubMed Web of Science ®Google Scholar
• Harper, U. W., G. R. Adami, N. Wei, K. Keyomars, and S. T. Elledge. 1993. The p21 Cdk-interacting protein Cip 1 is a potent inhibitor of G1 cyclindependent kinase. Cell 75:805–816.
   PubMed Web of Science ®Google Scholar
• Hogan, B., R. Beddington, F. Costantini, and E. Lacy. 1994. Manipulating the mouse embryo: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
   Google Scholar
• Huppi, K., D. Siwarski, J. Dosik, P. Michieli, M. Chedid, S. Reed, B. Mock, D. Givol, and J. F. Mushinski. 1994. Molecular cloning, sequencing, chromosomal localization and expression of mouse p21 (Waf-1). Oncogene 9:3017–3020.
   PubMedGoogle Scholar
• Johnson, P. F., and S. L. McKnight. 1989. Eukaryotic transcriptional regulatory proteins. Annu. Rev. Biochem. 58:799–839.
   PubMed Web of Science ®Google Scholar
• Johnson, P. F., and S. C. Williams. 1994. CCAAT/enhancer binding (C/EBP) proteins, p. 231–258. In M. Yaniv and F. Tronche (ed.), Liver gene expression. R. G. Landes Co., Austin, Tex.
   Google Scholar
• Key, M. A., F. Graham, F. Leland, and S. L. C. Woo. 1995. Therapeutic serum concentrations of human alpha-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes. Hepatology 21:815–819.
   PubMedGoogle Scholar
• Kong, A.-N. T., M. Ma, D. Tao, and L. Yang. 1993. Molecular cloning of two cDNAs encoding the mouse bilirubin/phenol family of UDP-glucuronosyltransferase (mUGT Br/p). Pharm. Res. 10:461–465.
   PubMedGoogle Scholar
• Kumar, V., R. S. Cotran, and S. L. Robbins. 1992. Basic pathology, 5th ed. The W. B. Saunders Co., Philadelphia, Pa.
   Google Scholar
• Lakso, M., J. G. Pichel, J. R. Gorman, B. Sauer, Y. Okamoto, E. Lee, F. W. Alt, and H. Westphal. 1996. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl. Acad. Sci. USA 93:5860–5865.
   PubMed Web of Science ®Google Scholar
• Lee, Y.-H., B. Saver, and F. J. Gonzalez. Unpublished data.
   Google Scholar
• Lee, Y.-H., M. Yano, S.-Y. Liu, E. Matsunaga, P. F. Johnson, and F. J. Gonzalez. 1994. A novel cis-acting element controlling the rat CYP2D5 gene and requiring cooperativity between C/EBPþ and an Sp1 factor. Mol. Cell. Biol. 14:1383–1394.
   PubMed Web of Science ®Google Scholar
• Lee, Y.-H., S. C. Williams, M. Baer, E. Sterneck, F. J. Gonzalez, and P. F. Johnson. 1997. The ability of C/EBPþ but not C/EBPa to synergize with an Sp1 protein is specified by the leucine zipper and activation domain. Mol. Cell. Biol. 17:2038–2047.
   PubMed Web of Science ®Google Scholar
• Li, Q., M. A. Kay, M. Finegold, L. D. Stratford-Perricaudet, and S. C. Woo. 1993. Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum. Gene Ther. 4:403–409.
   PubMed Web of Science ®Google Scholar
• Lieber, A., and M. A. Kay. 1996. Adenovirus-mediated expression of ribozymes in mice. J. Virol. 70:3153–3158.
   PubMed Web of Science ®Google Scholar
• Marie-Jeanne, T. F. D., V. Peeters, G. A. Patijn, A. Lieber, L. Meuse, and M. A. Kay. 1996. Adenovirus-mediated hepatic gene transfer in mice: comparison of intravascular and biliary administration. Hum. Gene Ther. 7:1693–1699.
   PubMedGoogle Scholar
• Marie-Jeanne, T. F. D., V. Peeters, A. Lieber, J. Perkins, and M. A. Kay. 1996. Method for multiple portal vein infusions in mice: quantitation of adenovirus-mediated hepatic gene transfer. BioTechniques 20:278–284.
   PubMedGoogle Scholar
• Nolten, L. A., F. M. A. Van Schaik, P. H. Steenbergh, and J. S. Sussenbach. 1994. Expression of the insulin-like growth factor I gene is stimulated by the liver-enriched transcription factors C/EBPa and LAP. Mol. Endocrinol. 8:1636–1645.
   PubMedGoogle Scholar
• Nolten, L. A., P. H. Steenbergh, and J. S. Sussenbach. 1995. Hepatocyte nuclear factor 1a activates promoter 1 of the human insulin-like growth factor I gene via two distinct binding sites. Mol. Endocrinol. 9:1488–1499.
   PubMedGoogle Scholar
• O’Brien, R. M., P. C. Lucas, T. Yamasaki, E. L. Noisin, and D. K. Granner. 1994. Potential convergence of insulin and cAMP signal transduction systems at the phosphoenolpyruvate carboxykinase (PEPCK) gene promoter through C/EBP. J. Biol. Chem. 269:30419–30428.
   PubMedGoogle Scholar
• O’Brien, R. M., E. L. Noisin, A. Suwanichkul, T. Yamasaki, P. C. Lucas, J.-C. Wang, D. R. Powell, and D. K. Granner. 1995. Hepatic nuclear factor 3- and hormone-regulated expression of the phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein 1 gene. Mol. Cell. Biol. 15:1747–1758.
   PubMed Web of Science ®Google Scholar
• Owens, I. S., and J. K. Rittaer. 1995. Gene structure at the human UGT1 locus creates diversity in isozyme structure, substrate specificity, and regulation. Prog. Nucleic Acid Res. Mol. Biol. 51:305–338.
   PubMedGoogle Scholar
• Park, E. A., W. J. Roesler, J. Liu, D. J. Klemm, A. I. Gurney, J. D. Thatcher, J. Shuman, A. Friedman, and R. W. Hanson. 1990. The role of the CCAAT/ enhancer-binding protein in the transcriptional regulation of the gene for phosphoenolpyruvate carboxykinase (GTP). Mol. Cell. Biol. 10:6264–6272.
   PubMedGoogle Scholar
• Park, E. A., W. J. Roesler, A. I. Gurney, S. E. Nizielshi, P. Hakimi, Z. Cao, A. Moorman, and R. W. Hanson. 1993. Relative roles of CCAAT/enhancerbinding protein and cAMP regulatory element-binding protein in controlling transcription of the gene for phosphoenolpyruvate carboxykinase (GTP). J. Biol. Chem. 268:613–619.
   PubMedGoogle Scholar
• Robertson, E. J. (ed.). 1987. Teratocarcinomas and embryonic stem cells: a practical approach. IRL Press, Oxford, United Kingdom.
   Google Scholar
• Rodenburg, R. J., W. Teertsra, P. E. Holthuizen, and J. S. Sussenbach. 1995. Postnatal liver-specific expression of human insulin-like growth factor II is highly stimulated by the transcription activators liver-enriched activating protein and CCAAT/enhancer binding protein-alpha. Mol. Endocrinol. 9:423–434.
   Google Scholar
• Rohlmann, A., M. Gotthardt, T. E. Willnow, R. E. Hammer, and J. Herz. 1996. Sustained somatic gene inactivation by viral transfer of cre recombinase. Nat. Biotechnol. 14:1562–1565.
   PubMed Web of Science ®Google Scholar
• Sasaki, K., T. P. Cripe, S. R. Koch, T. L. Andreone, D. D. Petersen, E. G. Beale, and D. K. Granner. 1984. Multihormonal regulation of phosphoenolpyruvate carboxykinase gene transcription. J. Biol. Chem. 259:15242–15252.
   PubMed Web of Science ®Google Scholar
• Sauer, B. 1993. Manipulation of transgenes by site-specific recombination: use of Cre recombinase. Methods Enzymol. 225:890–901.
   PubMed Web of Science ®Google Scholar
• Schaeffer, E., F. Guillou, D. Part, and M. M. Zakin. 1993. A different combination of transcription factors modulate the expression of the human transferrin promoter in liver and Sertoli cells. J. Biol. Chem. 268:23399.
   PubMedGoogle Scholar
• Theisen, M., R. R. Behringer, G. G. Cadd, R. L. Brinster, and G. S. McKnight. 1993. A C/EBP-binding site in the transferrin promoter is essential for expression in the liver but not in the brain of transgenic mice. Mol. Cell. Biol. 13:7666–7676.
   PubMed Web of Science ®Google Scholar
• Timchenko, N. A., M. Wilde, M. Kakanishi, J. R. Smith, and G. J. Darlington. 1996. CCAAT/enhancer-binding protein a (C/EBPa) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev. 10:804–815.
   PubMed Web of Science ®Google Scholar
• Trus, M., N. Benvenisty, H. Cohen, and L. Reshef. 1990. Developmentally regulated interactions of liver nuclear factors with the rat phosphoenolpyruvate carboxykinase promoter. Mol. Cell. Biol. 10:2418–2422.
   PubMedGoogle Scholar
• Wang, N.-D., M. J. Finegold, A. Bradley, C. N. Ou, S. V. Abdelsayed, M. D. Wilde, R. Taylor, D. R. Wilson, and G. J. Darlington. 1995. Impaired energy homeostasis in C/EBPa knockout mice. Science 269:1108–1112.
   PubMed Web of Science ®Google Scholar
• Wang, Y., L. A. Krushel, and G. M. Edelman. 1996. Targeted DNA recombination in vivo using an adenovirus carrying the cre recombinase gene. Proc. Natl. Acad. Sci. USA 93:3932–3936.
   PubMedGoogle Scholar
• Yang, Y., F. A. Nunes, K. Berencsi, E. E. Furth, E. Gonczol, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407–4411.
   PubMed Web of Science ®Google Scholar
• Yang, Y., Q. Li, H. C. J. Ertl, and J. M. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004–2015.
   PubMed Web of Science ®Google Scholar
• Yanuka-Kashles, O., H. Cohen, M. Trus, A. Aran, N. Benvenisty, and L. Reshef. 1994. Transcriptional regulation of the phosphoenolpyruvate carboxykinase gene by cooperation between hepatic nuclear factors. Mol. Cell. Biol. 14:7124–7133.
   PubMedGoogle Scholar